RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @FrezzaLab: Antibody responses to SARS-CoV-2 in patients with COVID-19 | Nature Medicine https://t.co/vMbpa9OZbM
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
المناعة في مواجهة الـ #كورونا
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @Rndubois: Human antibody responses to COVID-19: https://t.co/v0yFNd47Uy https://t.co/NTJQXhM6Ui
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
Looks promising.
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @mtmdphd: Antibody responses to SARS-CoV-2 in patients with COVID-19 [Apr 29, 2020] Long et al. @NatureMedicine https://t.co/NMeoxyKtfM…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @FrezzaLab: Antibody responses to SARS-CoV-2 in patients with COVID-19 | Nature Medicine https://t.co/vMbpa9OZbM
@chrismartenson Would love to know your thoughts on this. https://t.co/vTSrZxjl2r
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @mtmdphd: Antibody responses to SARS-CoV-2 in patients with COVID-19 [Apr 29, 2020] Long et al. @NatureMedicine https://t.co/NMeoxyKtfM…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
Antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within 19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G (IgG).
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @mtmdphd: Antibody responses to SARS-CoV-2 in patients with COVID-19 [Apr 29, 2020] Long et al. @NatureMedicine https://t.co/NMeoxyKtfM…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
Antibody responses to SARS-CoV-2 in patients with COVID-19 [Apr 29, 2020] Long et al. @NatureMedicine https://t.co/NMeoxyKtfM #COVID19 #CCC19 HT @ADesaiMD n=285. Within 19 days after symptom onset, 100% of patients tested positive for antiviral IgG https
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
Good antibody study. The IgM results are a bit surprising.
Antibody responses to SARS-CoV-2 in patients with COVID-19 https://t.co/m6ZCvCTNKw
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
@juliomayol
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @FrezzaLab: Antibody responses to SARS-CoV-2 in patients with COVID-19 | Nature Medicine https://t.co/vMbpa9OZbM
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
Fantastic study out today in @NatureMedicine characterizing the antibody responses in 285 #COVID19 patients. Insights into possible #AntibodyTesting in the future. @metricausa #Antibody #SARSCoV2
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
@SaneEpi Ja kun mietit serokonversioon kuluvaa aikaa kannattaa vilkuilla tänne: https://t.co/UnUrNyiYMp
Antibody responses to SARS-CoV-2 in patients with COVID-19 | Nature Medicine https://t.co/vMbpa9OZbM
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
It is very clear that rapid tests are not useful for early diagnosis of #COVID19 but for #immunityagainstcovid19 monitoring. The question is, patients who recover for how long are they protected?
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @NatureMedicine: A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COV…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
Human antibody responses to COVID-19: https://t.co/v0yFNd47Uy https://t.co/NTJQXhM6Ui
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
Éric Topol: L'évolution dans le temps et les schémas des anticorps IgG et IgM, la séroconversion après #COVID19 chez 285 patients https">@NatureMedicine">https://t.co/Ao2TKJMuGN@NatureMedicine hétérogénéité considérable des niveaux d'IgG (20 fois) et nombreuses nouvelles perspect
RT @ADesaiMD: “Antibody responses to #SARSCoV2 in patients with #COVID19” @NatureMedicine shows among 285 patients, IgG developed by day 19…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
RT @EricTopol: The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCY…
A cross-sectional study of hospitalized patients with #COVID19 and a longitudinal follow-up study of patients with #COVID_19 suggest that #SARS_COV_2-specific IgG or IgM seroconversion occurs within 20 days post symptom onset. #AntibodyTesting #Antibody.
The time course and patterns of IgG and IgM antibodies, seroconversion after #COVID19 in 285 patients https://t.co/NTgS0hKCYg @NatureMedicine considerable heterogeneity of IgG levels (20-fold) and many new insights https://t.co/6sTR0gXoct
新型コロナウイルス陽性の285人の患者において、2週間後にIgGが100%陽性に。IgMとIgGで上昇のタイミングに大きな差はない。 PR-PCRに代わって、IgGが良い診断基準になるかもしれません。(切れ味の良いキットがきちんと開発出来ればですが) https://t.co/4oa6EUjVPh
Need more data like this! Still unanswered questions-what happens after 2 weeks, what level of IgG establishes immunity (likely not binary, but dose/exposure dependent) #RESEARCHPAPER #physicians Antibody responses to #SARSCoV2 in patients with #COVID19 ht
RT @DrYukselUrun: ⭕️ #SARSCoV2 sonrası ortanca 19 günde IgG/IgM antikorları oluşuyor, serokonversiyon sonrası antikor titreleri 6 günde pla…
Antibody responses to #SARSCoV2 : ⭕️Within 19 days after symptom onset, 100% of pts tested (+) for antiviral IgG and plateaued in 6 days ⭕️It might be helpful for the Dx of pts with (-) RT–PCR and asymptomatic infections @OncoAlert #COVID19 https://t.co
⭕️ #SARSCoV2 sonrası ortanca 19 günde IgG/IgM antikorları oluşuyor, serokonversiyon sonrası antikor titreleri 6 günde platoya ulaşıyor. ⭕️RT-PCR negatif veya asemptomatik hastaların tanımlanması için yardımcı olabilir. #COVID19 @drfahrettinkoca https://
Interesting study on Ab response to COVID19